Loading...

Sanofi

SNW.DEXETRA
Healthcare
Drug Manufacturers - General
83.61
0.53(0.64%)

Sanofi SNW.DE Peers

See (SNW.DE) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - General Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
SNW.DE€83.61+0.64%101.9B16.76€4.99+4.69%
LLY.DE€659.70-1.26%625.2B62.65€10.53+0.73%
JNJ.DE€132.34-0.74%318.4B17.21€7.69+3.54%
4AB.DE€163.20+0.74%288.3B80.39€2.03+3.69%
ZEG.DE€120.70-0.66%187.2B28.00€4.31+2.27%
6MK.DE€70.20+0.43%176.3B11.70€6.00+4.23%
AMG.DE€252.70+6.38%135.9B26.49€9.54+3.35%
PFE.DE€21.48+0.68%122.1B17.90€1.20+7.49%
PFE.F€21.48+0.89%121.8B17.71€1.21+7.50%
GIS.DE€95.64+1.39%119B23.10€4.14+3.06%
Showing 1 to 10 of 15 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

SNW.DE vs LLY.DE Comparison

SNW.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SNW.DE stands at 101.9B. In comparison, LLY.DE has a market cap of 625.2B. Regarding current trading prices, SNW.DE is priced at €83.61, while LLY.DE trades at €659.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SNW.DE currently has a P/E ratio of 16.76, whereas LLY.DE's P/E ratio is 62.65. In terms of profitability, SNW.DE's ROE is +0.08%, compared to LLY.DE's ROE of +0.77%. Regarding short-term risk, SNW.DE is less volatile compared to LLY.DE. This indicates potentially lower risk in terms of short-term price fluctuations for SNW.DE.

Stock Price Comparison

Loading...

Frequently Asked Questions

;